These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38631183)

  • 41. Elevated cerebrospinal fluid interleukin-17A and interferon-γ levels in early asymptomatic neurosyphilis.
    Pastuszczak M; Jakiela B; Wielowieyska-Szybinska D; Jaworek AK; Zeman J; Wojas-Pelc A
    Sex Transm Dis; 2013 Oct; 40(10):808-12. PubMed ID: 24275734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CSF flow patterns in the brain in patients with neuro-Behçet disease and Behçet disease.
    Ünlü S; Doğan M; Kapicioğlu Y; Kamişli S; Öner S; Yildirim IO; Öztürk M
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3906-3910. PubMed ID: 28975972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of Th-17 and RORγt mRNA in Behçet's Disease.
    Hamzaoui K; Bouali E; Ghorbel I; Khanfir M; Houman H; Hamzaoui A
    Med Sci Monit; 2011 Apr; 17(4):CR227-34. PubMed ID: 21455110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr virus-encoded BART9 and BART15 miRNAs are elevated in exosomes of cerebrospinal fluid from relapsing-remitting multiple sclerosis patients.
    Mohammadinasr M; Montazersaheb S; Hosseini V; Kahroba H; Talebi M; Molavi O; Ayromlou H; Hejazi MS
    Cytokine; 2024 Jul; 179():156624. PubMed ID: 38692184
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two Japanese cases of anti-MOG antibody-associated encephalitis that mimicked neuro-Behçet's disease.
    Fujimori J; Takahashi T; Matsumoto Y; Fujihara K; Takai Y; Misu T; Nakashima I
    J Neuroimmunol; 2019 Sep; 334():577002. PubMed ID: 31279093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Untreated relapsing remitting multiple sclerosis patients show antibody production against latent Epstein Barr Virus (EBV) antigens mainly in the periphery and innate immune IL-8 responses preferentially in the CNS.
    Sisay S; Lopez-Lozano L; Mickunas M; Quiroga-Fernández A; Palace J; Warnes G; Alvarez-Lafuente R; Dua P; Meier UC
    J Neuroimmunol; 2017 May; 306():40-45. PubMed ID: 28385186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β.
    Rolla S; Bardina V; De Mercanti S; Quaglino P; De Palma R; Gned D; Brusa D; Durelli L; Novelli F; Clerico M
    J Leukoc Biol; 2014 Dec; 96(6):1155-64. PubMed ID: 25097195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The intrathecal expression and pathogenetic role of Th17 cytokines and CXCR2-binding chemokines in tick-borne encephalitis.
    Grygorczuk S; Świerzbińska R; Kondrusik M; Dunaj J; Czupryna P; Moniuszko A; Siemieniako A; Pancewicz S
    J Neuroinflammation; 2018 Apr; 15(1):115. PubMed ID: 29678185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis.
    Talbot J; Højsgaard Chow H; Mahler M; Buhelt S; Holm Hansen R; Lundell H; Vinther-Jensen T; Hellem MNN; Nielsen JE; Siebner HR; von Essen MR; Sellebjerg F
    Mult Scler Relat Disord; 2022 Dec; 68():104209. PubMed ID: 36257152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.
    Ahlbrecht J; Martino F; Pul R; Skripuletz T; Sühs KW; Schauerte C; Yildiz Ö; Trebst C; Tasto L; Thum S; Pfanne A; Roesler R; Lauda F; Hecker M; Zettl UK; Tumani H; Thum T; Stangel M
    Mult Scler; 2016 Aug; 22(9):1202-14. PubMed ID: 26493127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.
    Sonmez C; Yucel AA; Yesil TH; Kucuk H; Sezgin B; Mercan R; Yucel AE; Demirel GY
    Clin Rheumatol; 2018 Oct; 37(10):2797-2804. PubMed ID: 29557072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of IL-17AA and IL-17FF in rheumatoid arthritis and multiple sclerosis.
    Schofield C; Fischer SK; Townsend MJ; Mosesova S; Peng K; Setiadi AF; Song A; Baruch A
    Bioanalysis; 2016 Nov; 8(22):2317-2327. PubMed ID: 27620302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia.
    Houman MH; Bellakhal S; Ben Salem T; Hamzaoui A; Braham A; Lamloum M; Monia SK; Ben Ghorbel I
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2015-8. PubMed ID: 23830180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis.
    Ruocco G; Rossi S; Motta C; Macchiarulo G; Barbieri F; De Bardi M; Borsellino G; Finardi A; Grasso MG; Ruggieri S; Gasperini C; Furlan R; Centonze D; Battistini L; Volpe E
    Clin Sci (Lond); 2015 Aug; 129(4):291-303. PubMed ID: 25700150
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases.
    Wullschleger A; Kapina V; Molnarfi N; Courvoisier DS; Seebach JD; Santiago-Raber ML; Hochstrasser DF; Lalive PH
    PLoS One; 2013; 8(8):e72399. PubMed ID: 24015240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuro-Behcet's disease: An update on diagnosis, differential diagnoses, and treatment.
    Borhani-Haghighi A; Kardeh B; Banerjee S; Yadollahikhales G; Safari A; Sahraian MA; Shapiro L
    Mult Scler Relat Disord; 2020 Apr; 39():101906. PubMed ID: 31887565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A case of chronic progressive neuro-Behçet disease with extensive cerebral atrophy and elevated CSF IL-6 activity treated with infliximab].
    Hamada K; Takei R; Sakiyama Y; Moriyama H; Hashiguchi A; Takashima H
    Rinsho Shinkeigaku; 2018 Jan; 58(1):30-34. PubMed ID: 29269695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
    Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
    Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease.
    Hamzaoui K; Hamzaoui A; Ghorbel I; Khanfir M; Houman H
    Scand J Immunol; 2006 Dec; 64(6):655-60. PubMed ID: 17083622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.
    Wei Y; Chang H; Li X; Wang H; Du L; Zhou H; Xu W; Ma Y; Yin L; Zhang X
    Neuroimmunomodulation; 2018; 25(4):215-224. PubMed ID: 30544111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.